M&A Deal Summary

Roche Molecular Systems Acquires IQuum

On June 16, 2014, Roche Molecular Systems acquired healthcare services company IQuum for 450M USD

Acquisition Highlights
  • This is Roche Molecular Systems’ 1st transaction in the Healthcare Services sector.
  • This is Roche Molecular Systems’ largest (disclosed) transaction.
  • This is Roche Molecular Systems’ 1st transaction in the United States.
  • This is Roche Molecular Systems’ 1st transaction in Massachusetts.

M&A Deal Summary
Date 2014-06-16
Target IQuum
Sector Healthcare Services
Buyer(s) Roche Molecular Systems
Deal Type Add-on Acquisition
Deal Value 450M USD

Target

IQuum

Marlborough, Massachusetts, United States
IQuum is a privately held company focused on developing point of care offerings for the molecular diagnostics market.

Search 199,847 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Roche Molecular Systems

Pleasanton, California, United States
Category Company
Founded 1991
Sector Healthcare Services
DESCRIPTION

Roche Molecular Diagnostics (RMD) is a business area of Roche Diagnostics (Basel, Switzerland) that develops, manufactures and supplies a wide array of innovative medical diagnostic products, services, tests, platforms and technologies.

DEAL STATS #
Overall 1 of 1
Sector (Healthcare Services) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Massachusetts) 1 of 1
Country (United States) 1 of 1
Year (2014) 1 of 1
Size (of disclosed) 1 of 1
Mergr

Product

Company

Legal